{"doi":"10.1002/lio2.70202","title":"Obstacles to Obtain Care Among Sexual and Gender Minorities With Chronic Rhinosinusitis","abstract":"Objectives: This study aims to compare the prevalence of cost and non-cost barriers to healthcare access among sexual and gender minority (SGM) patients and non-SGM patients with chronic rhinosinusitis (CRS). Methods: The All of Us Research Program was queried for CRS patients, defined as having at least two diagnoses of chronic sinusitis (ICD10: J32.x). Patients were categorized based on questions regarding gender identity, biological sex, and self-descriptions. The primary outcome was cost and non-cost barriers. Multivariable logistic regression was used to examine SGM status and experiencing barriers to care. Results: 7708 patients with CRS were included; 595 were SGM and 7113 were non-SGM. SGM patients were significantly more likely to delay primary care (AOR: 1.51, 95% CI: 1.09-2.11), specialist care (AOR: 1.54, 95% CI: 1.18-2.00), mental healthcare (AOR: 1.70, 95% CI: 1.29-2.24), and filling prescription medication (AOR: 1.31, 95% CI: 1.03-1.66). Regarding non-cost barriers, SGM patients were significantly more likely to delay care because of transportation problems (AOR: 1.84, 95% CI: 1.39-2.42), their provider having a different background (AOR: 1.48, 95% CI: 1.14-1.90) and due to a lack of respect by their providers (AOR: 1.42, 95% CI: 1.16-1.73). Conclusion: SGM patients with CRS report multiple cost and non-cost barriers. While differences between CRS and non-CRS groups were modest, rhinologists and other healthcare practitioners treating SGM patients with CRS should be mindful of these disparities to address these barriers at a patient and system level. Level of Evidence: Level III, 2025.","journal":"Laryngoscope Investigative Otolaryngology","year":2025,"id":570490,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9601,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1475730,"name":"Najm S. Khan","orcid":"0000-0003-2701-4798","position":1,"is_corresponding":false},{"id":1475731,"name":"Heli Majeethia","orcid":"0009-0002-6172-7898","position":2,"is_corresponding":false},{"id":1385628,"name":"J Park","orcid":"0009-0005-5371-5071","position":3,"is_corresponding":false},{"id":1476072,"name":"Roshan Dongre","orcid":null,"position":4,"is_corresponding":false},{"id":1475732,"name":"Franklin Wu","orcid":"0000-0001-7361-401X","position":5,"is_corresponding":false},{"id":1401576,"name":"Ella Brissett","orcid":null,"position":6,"is_corresponding":false},{"id":1150661,"name":"Masayoshi Takashima","orcid":"0000-0001-9790-3529","position":7,"is_corresponding":false},{"id":1110905,"name":"Omar G. Ahmed","orcid":"0000-0001-9424-517X","position":8,"is_corresponding":false},{"id":1475729,"name":"F. Khan","orcid":"0009-0007-5507-2916","position":0,"is_corresponding":true}],"reference_count":23,"raw_metadata":null,"created_at":"2026-07-19T02:57:07.857542Z","pmid":"40677957","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}